Delivery Order SPE2DR25D1100-SPE2DR26FCU7M
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,108.65 on September 9, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens with a ceiling value of $1,107.42. This is a firm fixed-price delivery order with no set-aside designation, requiring completion by December 16, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $36,921.15 by the Defense Logistics Agency (DLA) on November 12, 2025, for the supply of Zepbound 15 mg/0.5 mL pens. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 13, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $9,716.14 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Zepbound 10 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract has an ultimate completion date of December 12, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $2,953.12 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 10, 2025. This delivery order is executed under...
- The Defense Logistics Agency awarded a $1,584.34 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed-price, non-competitive delivery order is set to be completed by August 19, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,163.59 on December 12, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injectors. The contract is a firm fixed-price delivery order with an ultimate completion date of December 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency awarded a $10,517.68 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Zepbound 15 mg/0.5 mL pens. This competitively awarded, firm fixed-price delivery order is set to be completed by December 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the federal government's pharmaceutical procurement through AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens with a ceiling value of $9,649.02. This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of December 12, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award includes no set-aside designation, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order valued at $48,084.36 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pens on December 16, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with the federal government. The product will be delivered to the company's...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCU7MDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,476.56 on December 15, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract has an ultimate completion date of December 16, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of the company's extensive portfolio of pharmaceutical supply contracts with the federal government, which encompass brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. No set-aside designation was used for this delivery order, consistent with AmerisourceBergen's competitive positioning as a major pharmaceutical distributor within the federal medical procurement system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/14/25 |